Status:
COMPLETED
Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance
Lead Sponsor:
The League of Clinical Research, Russia
Collaborating Sponsors:
National Research Center for Preventive Medicine
Conditions:
Lipid Metabolism Disorders
Eligibility:
All Genders
40-65 years
Brief Summary
A systematic collection of retrospective and prospective data based on non-interventional patient observation, aimed to assess the risks, course and outcomes of a disease or a group of diseases: * th...
Detailed Description
The research program will have two parts: Stage 1: identification of patients with moderate, high and very high cardiovascular risk, not having diseases of atherosclerotic genesis and requiring lipid...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Data on the following subjects is planned to be collected in the project:
- Aged from 40 to 65 years inclusively
- With a high (≥5%) cardiovascular risk measured by SCORE and low density lipoprotein (LDL) levels of ≥2,5 mmol/L, or with a very high (≥10%) cardiovascular risk measured by SCORE and LDL levels ≥1,8 mmol/L or With atherosclerotic stenosis of brachiocephalic arteries of \>50% in the absence of cerebrovascular disease
- Exclusion criteria:
- No contraindications to statin treatment and not taking stating at study entry.
- History of the following clinically significant events and conditions:
- (а) myocardial infarction (б) stroke (в) transient ischemic attack
- Presence of the following diseases at the time of a statin administration:
- (а) ischemic heart disease (б) heart failure (в) peripheral artery atherosclerosis (г) atherosclerotic stenosis of brachiocephalic arteries with cerebrovascular disease .
- Subjects must give their consent for processing of their personal data for the purposes of this scientific project.
Exclusion
Key Trial Info
Start Date :
June 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2020
Estimated Enrollment :
2912 Patients enrolled
Trial Details
Trial ID
NCT04863274
Start Date
June 21 2018
End Date
October 15 2020
Last Update
May 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
League of Clinical Research (LeagueCRR)
Moscow, Russia, 119590